Nested Therapeutics

Nested Therapeutics

Edit info

  • Founded: 2021
  • Location: Cambridge, MA
  • Employee range: 11 - 50
  • Clinical stage: Clin0
  • Therapy area: Oncology
  • Drug types: ONC
  • Lead product: NEST-1
  • Funding: $90M A Oct 2022; $35M prior to Oct 2022
  • Investors: Versant Ventures, Foresite Capital, Avidity Partners, Cowen Healthcare Investments, Section 32


nestedtx.com

linkedin.com

job board


Drug notes:

Nest-2 Clin0 oncology; Nest-3 RD oncology; Nest-4 RD oncology

About:

Nested Therapeutics is a pre-clinical company on a mission to revolutionize precision oncology by identifying and exploiting unique cancer vulnerabilities to develop tailored treatments. Their approach centers around next-generation, small-molecule drugs to target previously overlooked or undetected therapeutic pathways. Their platform integrates genomics, structural biology, biophysics, and computational biology, helping them uncover hidden mutations and design drugs to target them. This data-driven approach allows the targeting of cancers that haven't responded well to existing therapies and has the potential to expand treatment options for a broader range of cancer patients.

Jobs:

Post a job


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com